Cal Baier-Anderson, Ph.D., is a Health Scientist.
Ah, summer! It’s a great time to be outdoors, enjoying the warm, sunny weather. Before you go outside, be sure to grab your sunscreen, that essential product that protects against skin cancer and sun damage. But which kind of sunscreen is best? There is a mesmerizing array of sunscreen options, but for our purposes let’s limit the question to one: Nano or not nano?
Scott Walsh, MBA, is a Project Manager.
Nanotechnology is a global phenomenon: Organizations all over the world are working to develop and deploy nanotechnology applications. Interest in minimizing the potential health, environmental and safety risks of nanotechnology is similarly global. One of many indications: Over the past year, EDF and DuPont’s Nano Risk Framework has been downloaded more than 3,000 times in nearly 100 countries.
Recognizing the international interest in the Framework, EDF and DuPont have now made it available in three major languages: Mandarin, French, and Spanish. (The Framework’s executive summary is also available in Portuguese.) These translations will allow organizations around the world to better understand and apply the Framework’s guidance to assess, mitigate, and communicate about potential nanomaterial risks.
Richard Denison, Ph.D., is a Senior Scientist.
[Links to posts in this series: Part 1, Part 2, Part 3, Part 4, Part 5]
This final post in this series goes to the ultimate question, where the nanorubber really hits the road: Can EPA regulate an “existing” nanomaterial’s production, use, or disposal under TSCA? Read More
Richard Denison, Ph.D., is a Senior Scientist.
[Links to posts in this series: Part 1, Part 2, Part 3, Part 4, Part 5]
Let’s now turn to dissecting just how limited EPA’s authorities are both to collect information that companies already possess on their nanomaterials, and to require companies to generate and submit new information. Read More
Richard Denison, Ph.D., is a Senior Scientist.
[Links to posts in this series: Part 1, Part 2, Part 3, Part 4, Part 5]
This was going to be the last post in my series on the fate of nanomaterials under the Toxic Substances Control Act (TSCA), where I turn to what will likely be – at least in the near term – the most common regulatory scenario that will apply: the extent to which EPA has authority to regulate nanomaterials as “existing” chemicals under TSCA. But there’s so much to cover that I’ve decided to split this last topic into three separate posts. Read More
John Balbus, M.D., M.P.H., is Chief Health Scientist.
A new paper by Shaw et al., published in May in the Proceedings of the National Academy of Sciences, “suggests a generalizable and scalable method for the systematic characterization and comparison of novel nanomaterials” using high throughput in vitro tests. Does this mean that the National Academy of Sciences’ vision for toxicity testing in the 21st century – proposed for conventional chemicals – is already here for nanomaterials? Not quite. Read More
